Alpha-Bromocriptine New Zealand - English - Medsafe (Medicines Safety Authority)

alpha-bromocriptine

apotex nz ltd - bromocriptine mesilate 11.48mg equivalent to 10 mg bromocryptine - tablet - 10 mg - active: bromocriptine mesilate 11.48mg equivalent to 10 mg bromocryptine excipient: butylated hydroxyanisole lactose monohydrate magnesium stearate maize starch sodium starch glycolate sunset yellow fcf tragacanth

Apo-Bromocriptine New Zealand - English - Medsafe (Medicines Safety Authority)

apo-bromocriptine

apotex nz ltd - bromocriptine mesilate 2.9mg equivalent to bromocriptine 2.5 mg (2.9 - 3.0 mg) - tablet - 2.5 mg - active: bromocriptine mesilate 2.9mg equivalent to bromocriptine 2.5 mg (2.9 - 3.0 mg) excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - prolactin dependent menstrual cycle disorders (amenorrhoea, oligomenorrhoea, galactorrhoea), and/or female infertility associated with hyperprolactinaemia or luteal phase deficiency: · bromocriptine may normalise the menstrual cycle and/or induce ovulation without ovarian overstimulation. treatment with bromocriptine is not curative and it is not effective in treating ovarian failure.

Bromocriptine 2.5mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bromocriptine 2.5mg tablets

mawdsley-brooks & company ltd - bromocriptine mesilate - oral tablet - 2.5mg